Ian Clarke

1.3k total citations
18 papers, 1.0k citations indexed

About

Ian Clarke is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Ian Clarke has authored 18 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Oncology and 4 papers in Hematology. Recurrent topics in Ian Clarke's work include Multiple Myeloma Research and Treatments (4 papers), Bone health and treatments (3 papers) and Liquid Crystal Research Advancements (3 papers). Ian Clarke is often cited by papers focused on Multiple Myeloma Research and Treatments (4 papers), Bone health and treatments (3 papers) and Liquid Crystal Research Advancements (3 papers). Ian Clarke collaborates with scholars based in United Kingdom, Slovakia and Italy. Ian Clarke's co-authors include Angus Dalgleish, J. Blake Bartlett, David Stirling, Keith Dredge, George W. Muller, J B Marriott, Robert Knight, Stephen Schey, Paul Fields and Matthew Streetly and has published in prestigious journals such as Journal of Clinical Oncology, Applied and Environmental Microbiology and Chemical Communications.

In The Last Decade

Ian Clarke

18 papers receiving 997 citations

Peers

Countries citing papers authored by Ian Clarke

Since Specialization

Citations

This map shows the geographic impact of Ian Clarke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian Clarke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian Clarke more than expected).

Fields of papers citing papers by Ian Clarke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian Clarke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian Clarke. The network helps show where Ian Clarke may publish in the future.

Co-authorship network of co-authors of Ian Clarke

This figure shows the co-authorship network connecting the top 25 collaborators of Ian Clarke. A scholar is included among the top collaborators of Ian Clarke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian Clarke. Ian Clarke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Stability of pemetrexed disodium in sodium chloride 0.9% w/v intravenous Viaflo infusion bags 2021 ·European Journal of Hospital Pharmacy ·Luke Nelson, (unknown), (unknown), (unknown), Lyndsay Davies, (unknown), (unknown), Ian Clarke	1
2	Identification of secondary targets of N-containing bisphosphonates in mammalian cells via parallel competition analysis of the barcoded yeast deletion collection 2009 ·Genome biology ·Nicoletta Bivi, Milena Romanello, Richard J. Harrison, Ian Clarke, David C. Hoyle, Luigi Moro, Fulvia Ortolani, Antonella Bonetti, Franco Quadrifoglio, Gianluca Tell, Daniela Delneri	22
3	Application of the comprehensive set of heterozygous yeast deletion mutants to elucidate the molecular basis of cellular chromium toxicity 2007 ·Genome biology ·Sara L. Holland, E. M. Lodwig, Theodora Sideri, Tom Reader, Ian Clarke, (unknown), David C. Hoyle, Daniela Delneri, Stephen G. Oliver, Simon V. Avery	51
4	Genotypic and Physiological Characterization of Saccharomyces boulardii , the Probiotic Strain of Saccharomyces cerevisiae 2007 ·Applied and Environmental Microbiology ·(unknown), Paul Gitsham, (unknown), G. Warhurst, Ian Clarke, David C. Hoyle, Stephen G. Oliver, Lubomira Stateva	161
5	Phase I study to determine the safety, tolerability and immunostimulatory activity of thalidomide analogue CC-5013 in patients with metastatic malignant melanoma and other advanced cancers 2004 ·British Journal of Cancer ·J. Blake Bartlett, (unknown), Ian Clarke, Keith Dredge, Steve Nicholson, Hartmut Kristeleit, (unknown), H. Pandha, George W. Muller, David Stirling, Jerome B. Zeldis, Angus Dalgleish	123
6	Phase I Study of an Immunomodulatory Thalidomide Analog, CC-4047, in Relapsed or Refractory Multiple Myeloma 2004 ·Journal of Clinical Oncology ·Stephen Schey, Paul Fields, J. Blake Bartlett, Ian Clarke, (unknown), Robert Knight, Matthew Streetly, Angus Dalgleish	232
7	A novel subclass of thalidomide analogue with anti-solid tumor activity in which caspase-dependent apoptosis is associated with altered expression of bcl-2 family proteins. 2003 ·PubMed ·J B Marriott, Ian Clarke, Anna Czajka, Keith Dredge, Kay Childs, Hon‐Wah Man, Peter Schäfer, (unknown), George W. Muller, David Stirling, Angus Dalgleish	45
8	Coxsackie B and adenovirus receptor, integrin and major histocompatibility complex class I expression in human prostate cancer cell lines: implications for gene therapy strategies 2003 ·Prostate Cancer and Prostatic Diseases ·Hardev Pandha, Luke H. Stockwin, J.D. Eaton, Ian Clarke, Angus Dalgleish, Stephen Todryk, G. Eric Blair	22
9	A randomized phase II trial of SRL172 (Mycobacterium vaccae) ± low-dose interleukin-2 in the treatment of metastatic malignant melanoma 2003 ·Melanoma Research ·Steve Nicholson, (unknown), (unknown), Ian Clarke, John F.X. Diffley, Paul Donnellan, (unknown), (unknown), Angus Dalgleish	21
10	Nitrogen Containing Bisphosphonates Induce Apoptosis and Inhibit the Mevalonate Pathway, Impairing Ras Membrane Localization in Prostate Cancer Cells 2003 ·The Journal of Urology ·Grenville Oades, S G Senaratne, Ian Clarke, Roger Kirby, Kay W. Colston	115
11	Mechanisms of bisphosphonate induced apoptosis in prostate cancer 2002 ·European Urology Supplements ·Grenville Oades, S G Senaratne, Ian Clarke, Roger Kirby, Kay W. Colston	1
12	Thalidomide and its analogues have distinct and opposing effects on TNF-αand TNFR2 during co-stimulation of both CD4+ and CD8+ T cells 2002 ·Clinical & Experimental Immunology ·J B Marriott, Ian Clarke, Keith Dredge, George W. Muller, David Stirling, Angus Dalgleish	127
13	Inhibition of p38 MAP kinase during cellular activation results in IFN-γ-dependent augmentation of IL-12 production by human monocytes/macrophages 2001 ·Clinical & Experimental Immunology ·J B Marriott, Ian Clarke, Angus Dalgleish	17
14	Human tumour and dendritic cell hybrids generated by electrofusion: potential for cancer vaccines 2000 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·(unknown), Ruth Pettengell, Ian Clarke, Gernot Stuhler, (unknown), Peter Walden, Angus Dalgleish	76
15	Thin films of liquid crystal fumarates and a related acrylate 1997 ·Thin Solid Films ·Maria Bardosova, Ian Clarke, Philip Hodge, R.H. Tredgold, (unknown)	6
16	Photo-polymerisation of thin films of compounds having terminal triple bonds 1997 ·Thin Solid Films ·Maria Bardosova, Ian Clarke, Philip Hodge, R.H. Tredgold	1
17	Thin films of a chiral liquid crystal fumarate 1997 ·Supramolecular Science ·Maria Bardosova, Ian Clarke, Philip Hodge, R.H. Tredgold, (unknown)	2
18	Stabilisation of smectic thin films by ultraviolet radiation 1996 ·Chemical Communications ·Maria Bardosova, Ian Clarke, Philip Hodge, R.H. Tredgold, (unknown)	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact